Background
==========

*Klebsiella pneumoniae*, a member of *Enterobacteriaceae*, is a rod-shaped gram-negative opportunistic pathogen. A common cause of nosocomial infection, it is also found in various community-acquired infections, including bacteraemia, septicaemia, and urinary tract and respiratory infections, particularly in immunocompromised patients \[[@B1]-[@B4]\]. In Asian countries, especially Taiwan and Korea, *K. pneumoniae* is the predominant pathogen found in pyogenic liver abscess in diabetic patients \[[@B2],[@B3],[@B5]\]. The rapid development of antimicrobial resistance in *K. pneumoniae* has further troubled the clinical choices for treatments \[[@B6],[@B7]\]. Studies of the pathogenic mechanisms of *K. pneumoniae* are, therefore, essential in identifying new targets for the development of antibacterial agents.

Multiple virulence factors have been identified to be involved in *K. pneumoniae* infection, which include capsular polysaccharide (CPS), lipopolysaccharides, fimbriae, iron-acquisition system, and antibiotic resistance. Among these factors, CPS is probably considered the major determinants of pathogenesis. The pyogenic liver abscess isolates often carry heavy CPS that could protect the bacteria from phagocytosis and killing by serum factors \[[@B8],[@B9]\]. Apart from the antiphagocytic function, *Klebsiella* CPS also helps the bacterial colonization and biofilm formation at the infection sites \[[@B10]-[@B12]\]. The capsular serotypes of *K. pneumoniae* have been classified as more than 77 recognized capsular antigens \[[@B13],[@B14]\]. In Taiwan, a high prevalence of K1 and K2 serotypes of *K. pneumoniae* was documented in liver abscess of diabetes mellitus patients \[[@B15]\]. The *cps* gene clusters that are responsible for the synthesis of different serotypes of CPS have been determined \[[@B16]\]. The K2 *cps* gene cluster of *K. pneumoniae* Chedid contains a total number of 19 open reading frames (ORFs) organized into three transcription units, *orf1-2orf3-15*, and *orf16-17*\[[@B16]\]. In the previous studies, numerous regulatory systems were demonstrated to control the biosynthesis of CPS via regulating the *cps* transcriptions in *K. pneumoniae*, such as the Rcs system, RmpA, RmpA2, KvhR, KvgAS, and KvhAS \[[@B17]-[@B20]\]. Among these, ferric uptake regulator (Fur) represses the gene expression of *rcsArmpA*, and *rmpA2* to decrease CPS biosynthesis \[[@B21],[@B22]\]. Therefore, overlapping regulons governed the regulation of these assorted virulence genes in response to numerous stress conditions.

Bacterial cells are constantly challenged by various environmental stresses from their natural habitats. Similar to many gastrointestinal (GI) pathogens, *K. pneumoniae* faces several challenges during infection and colonisation of the human body. These include gastric acid, the immune system, and a limited supply of oxygen and nutrients \[[@B23],[@B24]\]. Among these, the concentration of iron in the environment is critical for the control of cellular metabolism. Limitation of iron abolishes bacterial growth, but high intracellular concentrations of iron may damage bacteria because of the formation of undesired reactive oxygen species (ROS). Iron homeostasis maintained by the transport, storage, and metabolism of iron is tightly controlled by Fur in many gram-negative bacteria \[[@B25]-[@B27]\]. To regulate gene transcription, Fur protein functions as a dimer with Fe^2+^ as a cofactor to bind to a 19-bp consensus sequence, called the Fur box (GATAATGATwATCATTATC; w = A or T), in the promoters of downstream genes \[[@B28]\]. In several gram-negative pathogens, Fur represses the expression of genes involved in iron homeostasis and in the regulation of multiple cellular functions such as oxidative stress, energy metabolism, acid tolerance, and virulence gene production \[[@B29]-[@B32]\]. In *K. pneumoniae*, Fur plays a dual role in controlling CPS biosynthesis and iron acquisition \[[@B21]\]. Recently, we also found that type 3 fimbriae expression and bacterial biofilm formation were also controlled by Fur and iron availability \[[@B33]\]. Therefore, the regulatory mechanism of Fur in control of multiple cellular function and virulence factors in *K. pneumoniae* needs to be further investigated.

Although Fur typically acts as a repressor, it also functions as a transcriptional activator for the gene expression such as *acnAfumA*, and *sdhCDAB* (tricarboxylic acid \[TCA\] cycle enzymes), *bfr* and *ftnA* (iron storage), and *sodB* (iron superoxide dismutase \[FeSOD\]) \[[@B34]-[@B38]\]. However, positive regulation by Fur is often indirect, mediated by Fur-dependent repression of a small non-coding RNA (sRNA), RyhB \[[@B39]\]. RyhB negatively regulates gene expression by base pairing with mRNAs to trigger their degradation via RNase E and RNase III \[[@B40]\]. In many bacteria, RyhB participates in Fur-mediated positive regulation of various important cellular functions, including TCA cycle activity, resistance to oxidative stress, and iron homeostasis in *Escherichia coli* and *Vibrio cholerae*\[[@B35],[@B39],[@B41]-[@B43]\]; biofilm formation in *V. cholerae*\[[@B44]\]; and virulence in *Shigella dysenteriae*\[[@B45]\]. In *E. coli*, RyhB has been demonstrated to directly regulate more than 18 transcripts, encoding a total of 56 proteins, most of them involved in iron metabolism \[[@B35]\]. Although the significance of RyhB has been demonstrated in different species, to date, the regulatory relationship of RyhB and Fur, and functionality of RyhB in *K. pneumoniae* has not been studied.

In this study, the regulatory role of Fur in *ryhB* expression in *K. pneumoniae* was investigated. A *ryhB*-deletion mutant in wild type (WT) and Δ*fur* strains and the induced expression of *ryhB* in WT were generated to demonstrate the role of RyhB in mediating CPS biosynthesis and iron acquisition systems.

Results
=======

Fur directly represses *ryhB* expression in *K. pneumoniae*
-----------------------------------------------------------

To determine whether *K. pneumoniae ryhB* is regulated by Fur, a LacZ reporter system was used. The *ryhB* promoter was cloned into the upstream region of a promoterless *lacZ* gene in placZ15. The resulting plasmid pRyhB15 was then introduced into *K. pneumoniae* CG43S3 Δ*lacZ* and Δ*lacZ*Δ*fur.* The bacterial β-galactosidase activity was measured to assess the expression level of *ryhB*. As shown in Figure [1](#F1){ref-type="fig"}A, the expression of *ryhB* was higher in Δ*lacZ*Δ*fur* than Δ*lacZ*. Introduction of the complement plasmid p*fur*, but not the empty vector control (pRK415), into Δ*lacZ*Δ*fur* restored the Fur-deletion effect. Moreover, addition of the iron chelator 2, 2-dipyridyl (Dip) to the growth medium increased *ryhB* promoter activity, suggesting that a Fur-Fe(II) complex influences *ryhB* expression. To verify that Fur directly regulates the expression of *ryhB*, an electrophoretic mobility shift assay (EMSA) was performed. As shown in Figure [1](#F1){ref-type="fig"}B, purified recombinant His~6~-Fur protein was able to bind the upstream region of *ryhB* (P~*ryhB*~), but not the P~*ryhB\**~ fragment, whose putative Fur-box was deleted. In addition, the binding ability was abolished by the addition of 200 μM EDTA to the reaction mixture (data not shown). Furthermore, *E. coli* H1717, when harbouring a plasmid containing *K. pneumoniae* P~*ryhB*~, also showed a Fur titration assay (FURTA)-positive phenotype (Figure [1](#F1){ref-type="fig"}C). The results suggest that, in an iron dependent manner, Fur suppresses *ryhB* promoter activity in *K. pneumoniae* by direct interaction with the Fur-box region upstream of *ryhB*.

![**Fur directly represses the expression of*ryhB*.** (**A**) The β-galactosidase activities of the *K. pneumoniae* CG43S3Δ*lacZ* strain and the isogenic *fur* deletion mutant carrying pRyhB15 (P~*ryhB*~::*lacZ*) were determined from overnight cultures grown in LB with or without Dip. The plasmids pRK415 (vector control) and p*fur* were introduced into Δ*fur* to observe the complement effect. The average of triplicate experiments is shown. Error bars indicate standard deviations. (**B**) EMSA of the recombinant His~6~::Fur and the *ryhB* promoter regions, as indicated in the margin. DNA was incubated with an increasing amount of His~6~::Fur for 30 min, and then loaded onto a 5% non-denaturing polyacrylamide gel. The gel was stained with SYBR Green EMSA stain and photographed. P~*ryhB*~\* indicates deletion of the *fur* box in P~*ryhB*~. (**C**) Assessment of the binding of Fur to the *ryhB* promoter by using the FURTA. *E. coli* H1717 strains carrying the vector control, pT7-7, or the P1 region harboured on pT7-7 are indicated. A red colony (Lac^+^) is considered to have a FURTA-positive phenotype.](1471-2180-12-148-1){#F1}

RyhB activates CPS biosynthesis
-------------------------------

In *K. pneumoniae* CG43, we found that the deletion of *fur* resulted in elevated CPS production \[[@B21],[@B22]\]. To investigate if RyhB participates in Fur-regulated CPS biosynthesis, the CPS amount was assessed using measuring glucuronic acid content, which served as an indicator for *Klebsiella* K2 CPS \[[@B46]\], in *K. pneumoniae* strains, including WT, Δ*ryhB*, Δ*fur*, and Δ*fur*Δ*ryhB*, was quantified. As shown in Figure [2](#F2){ref-type="fig"}A, although the deletion of *ryhB* alone did not change on the amount of K2 CPS production, the elevated CPS amount in Δ*fur* cells was abolished by the deletion of *ryhB* when the bacteria were grown in LB medium. The result indicates that Fur regulates the expression of RyhB to repress CPS biosynthesis. To confirm the RyhB expression could activate the CPS biosynthesis, the effect of RyhB induction on CPS amount was determined using an IPTG-inducible vector, pETQ. As shown in Figure [2](#F2){ref-type="fig"}B, the induced expression of *ryhB* in *K. pneumoniae* CG43 increased CPS production, which confirms that RyhB positively regulates CPS biosynthesis.

![**RyhB activates CPS biosynthesis.** (**A**) Comparison of CPS levels in WT, Δ*ryhB*, Δ*fur*, and Δ*fur*Δ*ryhB* strains. Bacterial strains were grown in LB medium at 37°C with agitation. After 16 h of growth, the bacterial glucuronic acid content was determined. \*, *P* \< 0.001 compared with WT. (**B**) WT strains carrying the vector control (pETQ) or pETQ-*ryhB* were grown in LB with 100 μM IPTG to induce *ryhB* expression. \*, *P* \< 0.001 compared with WT strains carrying pETQ.](1471-2180-12-148-2){#F2}

RyhB increased the transcriptional level of the K2 *cps* gene cluster
---------------------------------------------------------------------

To investigate whether RyhB affects the expression of the three *cps* gene clusters, the mRNA levels of *orf1orf3*, and *orf16* in Δ*fur* and Δ*fur*Δ*ryhB* strains were measured by quantitative real-time PCR (qRT-PCR). As shown in Figure [3](#F3){ref-type="fig"}A, compared to the mRNA levels in the Δ*fur* strain, the mRNA levels of *orf1* and *orf16* were apparent decreased in the Δ*fur*Δ*ryhB* strain, and that of *orf3* also had a slight reduction in the Δ*fur*Δ*ryhB* strain. The result suggests that overexpression of RyhB activated the *cps* gene expression. To confirm our hypothesis, the effect of *ryhB* induction on the mRNA levels of *orf1orf3*, and *orf16* was tested using an IPTG-inducible vector, pETQ. As shown in Figure [3](#F3){ref-type="fig"}B, the mRNA levels of *orf1* and *orf16* were higher in the pETQ-*ryhB* strain with IPTG induction than the pETQ mock strain, while no significant difference in *orf3* expression was observed. To further investigate whether RyhB acts as a transcriptional activator for the promoter activity of *orf1orf3*, and *orf16*, the reporter plasmids pOrf12 (P~*orf1-2*~::*lacZ*), pOrf315 (P~*orf3-15*~::*lacZ*), and pOrf1617 (P~*orf16-17*~::*lacZ*), each carrying a *lacZ* reporter gene transcriptionally fused to the putative promoter region of the K2 *cps* gene cluster \[[@B17]\], were used to transform the *K. pneumoniae* strains CG43S3Δ*lacZ*Δ*fur* and Δ*lacZ*Δ*fur*Δ*ryhB*. The promoter activity measurements shown in Figure [3](#F3){ref-type="fig"}C revealed that the deletion of *ryhB* in Δ*lacZ*Δ*fur* reduced activity of P~*orf1-2*~::*lacZ* by at least 50%, while no obvious change was detected in the activity of P~*orf3-16*~::*lacZ*. The activity of P~*orf16-17*~::*lacZ* was reduced by more than 75% in Δ*lacZ*Δ*fur*Δ*ryhB* as compared to the Δ*lacZ*Δ*fur* strain*.* These results imply that RyhB enhances CPS biosynthesis in *K. pneumoniae* by boosting the transcriptional level of the *orf1* and *orf16* gene clusters.

![**RyhB activates the transcriptional level of the*orf1*and*orf16*.** (**A**) qRT-PCR analyses of the expression of the K2 *cps* genes (*orf1*, *orf3*, and *orf16*) were measured in Δ*fur* and Δ*fur*Δ*ryhB* strains. (**B**) WT strain carrying the IPTG inducible vector pETQ and pETQ-*ryhB* in response to 100 μM IPTG. (**C**) The β-galactosidase activities of *K. pneumoniae* CG43S3Δ*lacZ*Δ*fur* and Δ*lacZ*Δ*fur*Δ*ryhB* carrying the reporter plasmid pOrf12 (P~*orf1-2*~::*lacZ)*, pOrf315 (P~*orf3-15*~::*lacZ)* or pOrf1617 (P~*orf16-17*~::*lacZ)* were determined using log-phased cultures grown in LB broth. The results shown are an average of triplicate samples. Error bars indicate standard deviations.](1471-2180-12-148-3){#F3}

RyhB does not affect the *rcsA*, *rmpA2*, and *rmpA* mRNA expression level
--------------------------------------------------------------------------

In previous studies, *K. pneumoniae* Fur was found to repress the expression of genes encoding the *cps* regulatory proteins RcsA, RmpA, and RmpA2 \[[@B21],[@B22]\]. To investigate whether RyhB affects the expression of *rcsArmpA*, and *rmpA2* to increase the *orf1* and *orf16* transcripts, the mRNA levels were measured by qRT-PCR after inducing the expression of *ryhB* in WT. However, qRT-PCR results did not show a significant effect of *ryhB* on the mRNA levels of *rmpArmpA2*, and *rcsA* (Data not shown), suggesting that the activation of RyhB on the *orf1* and *orf16* expression is not via RmpA, RmpA2, and RcsA.

Deletion of *ryhB* attenuated the higher serum resistance in Δ*fur* strain
--------------------------------------------------------------------------

In addition to the roles played by RyhB and Fur in regulating the CPS amount, we suggest that RyhB and Fur may also affect the ability of the strain to resist the bactericidal effects of serum. In a human serum resistance assay, we found that the deletion of *fur* in WT increased the survival rate in treatment with 75% normal human serum from 63.3% to 87.9% (Figure [4](#F4){ref-type="fig"}). However, the deletion of *ryhB* in WT had no apparent effect on the survival rate on treatment with 75% serum, and the higher serum resistance in Δ*fur* cells was abolished by the deletion of *ryhB.* This result indicates that RyhB may participate with Fur in regulating serum resistance in *K. pneumoniae*.

![**Effect of Fur and RyhB on susceptibility to normal human serum.** Survival percentage of WT, Δ*ryhB*, Δ*fur*, Δ*fur*Δ*ryhB*, and Δ*galU* (negative control) strains on treatment with 75% healthy human serum was determined, respectively*.* The results shown are an average of triplicate samples. Error bars indicate standard deviations.](1471-2180-12-148-4){#F4}

The regulatory role of RyhB in iron-acquisition systems
-------------------------------------------------------

To assess whether RyhB affects iron-acquisition in *K. pneumoniae*, the Chrome azurol S (CAS) assay was used to measure siderophore secretions in Δ*fur* and Δ*fur*Δ*ryhB* strains (Figure [5](#F5){ref-type="fig"}). When bacteria were grown in M9 minimal medium (\~2 μM iron) to mimic iron-limited condition, the deletion of *ryhB* in Δ*fur* reduced the formation of the orange halo. However, this change was not observed when bacteria were grown in LB medium (\~18 μM iron). Compared to M9 minimal medium contains \~2 μM iron, LB medium is considered an iron-repletion medium. Under iron-repletion, Fur is able to exert its repression on *ryhB* transcription. Thus, *ryhB*-deletion effect is difficult to observed under the growth condition that *ryhB* is poorly expressed. Our results suggest that in the regulation of iron-acquisition systems, RyhB plays a role downstream of Fur in *K. pneumoniae* under iron-limiting conditions.

![**Deletion of*ryhB*decreases*K. pneumoniae*Δ*fur*siderophore production assessed using CAS assay.** Each of the strains, Δ*fur* and Δ*fur*Δ*ryhB*, was grown overnight in LB medium or M9 minimal medium, and then 5 μl each of cultures respectively was added onto a CAS agar plate. The orange halos formed around the colonies correspond to the iron-chelating activity of the siderophores in bacteria.](1471-2180-12-148-5){#F5}

To investigate the effects on downstream targets of RyhB in iron-acquisition regulons, the expression of genes corresponding to the eight putative iron-acquisition systems in *K. pneumoniae* CG43 was measured in Δ*fur* and Δ*fur*Δ*ryhB* by qRT-PCR (Table [1](#T1){ref-type="table"}). In M9 minimal medium, the expression of genes (*iucA*, *fepA*, *fepB*, *entC*, *fecA*, and *fecE*) corresponding to three iron-acquisition systems (aerobactin, enterobactin, and ferric citrate) was decreased by half in the Δ*fur*Δ*ryhB* strain (Δ*fur*Δ*ryhB*/Δ*fur* \< 0.5). However, the expression of *fhuA* and *sitA* was significantly increased more than two-fold (Δ*fur*Δ*ryhB*/Δ*fur* \> 2.0). These results imply that RyhB activates the expression of *iucA*, *fepA*, *fepB*, *entC*, *fecA*, and *fecE*, but represses the expression of *fhuA* and *sitA*.

###### 

**qRT-PCR analyses of the expression of iron-acquisition genes in*K. pneumoniae*Δ*fur*Δ*ryhB*and Δ*fur*strains**

  **Systems**      **Gene**    **RNA expression ratio**^a^
  ---------------- ---------- -----------------------------
  Fe^3+^                                     
  Ferrichrome      *fhuA*              2.62 ± 0.07
  Aerobactin       *iucA*              0.19 ± 0.06
  Enterobactin     *fepA*              0.36 ± 0.01
                   *fepB*              0.33 ± 0.05
                   *entC*              0.46 ± 0.02
  Ferric citrate   *fecA*              0.19 ± 0.02
                   *fecE*              0.34 ± 0.03
  Salmochelin      *iroB*              0.52 ± 0.05
  Heme             *hmuR*              0.69 ± 0.01
  Fe^2+^                                     
  Ferrous iron     *feoB*              0.55 ± 0.18
                   *sitA*              2.81 ± 0.08

^a^ Mean expression ratio (±SD) of Δ*fur*Δ*ryhB* relative to Δ*fur*.

Discussion
==========

In this study, we provide an initial characterisation of *K. pneumoniae* RyhB*.* In *K. pneumoniae*, sequence comparison indicated that the nucleotide sequence of the *ryhB* gene (91 bp) is 92.3% identical to the *E. coli* version (90 bp). However, the promoter sequence of *K. pneumoniae ryhB* is only 72.4% identical to that of *E. coli*. In this study, we found that the expression of *ryhB* in *K. pneumoniae* is directly repressed by Fur-Fe(II), as is the case in *E. coli* (Figure [1](#F1){ref-type="fig"}).

In addition, structure of the genomic neighbourhood of *ryhB* differs between the 2 species. In the *E. coli* genome, *ryhB* is found between *yhhX* and *yhhY*. In the *K. pneumoniae* genome, *ryhB* is flanked by *yhhY* and a hypothetical ORF. By Pfam search, the hypothetical ORF was found to contain a bactofilin domain (E-value = 3.7e-24), which belongs to a new class of polymer-forming proteins that serve as versatile molecular scaffolds in a variety of cellular pathways \[[@B47]\]. Even though the function of this hypothetical protein in *K. pneumoniae* has not yet been investigated, we found that RyhB could strongly repress the expression of this hypothetical protein (unpublished data). This result suggests that RyhB could participate in a variety of cellular pathways in *K. pneumoniae*.

We previously showed in *K. pneumoniae*, Fur represses CPS biosynthesis via regulation of RmpA, RmpA2, and RcsA. In addition to these 3 regulators, one or more regulators may be involved in the Fur-mediated control of *cps* transcription \[[@B21]\]. In this study, we found that RyhB also participates in Fur-regulated CPS biosynthesis via activation of *orf1* and *orf16* transcription and is independent of the 3 regulators, RmpA, RmpA2, and RcsA (Figure [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). We want to further analyse whether any potential transcriptional regulator-binding motifs exist in the promoter sequences of *orf1* and *orf16*. We noted that a binding site typical of IscR, a transcriptional repressor that controls Fe--S biosynthesis \[[@B48]\], was located 172 bp upstream of the translation start site of GalF (encoded by *orf1,* 5′-[ATAACCTGA]{.ul}ACGAAAA[T]{.ul}A[AG]{.ul}A[TTAT]{.ul}-3′). The predication indicated that IscR could participate in control of *orf1* expression. Furthermore, a previous study reported that RyhB promotes the degradation of *iscSUA* transcripts, resulting in an increase in the ratio of apo-IscR/holo-IscR \[[@B48]\]. Whether RyhB activates CPS biosynthesis via regulation of the ratio of apo-IscR/holo-IscR in *K. pneumoniae* awaits further analysis. However, the regulatory mechanism of *cps* transcription is more complex than expected; whether another unknown transcriptional regulator is involved in activation of RyhB's effect on *orf16* transcription needs to be investigated. In addition, CPS is considered the major determinant that can protect the bacteria from phagocytosis and killing by serum factors \[[@B8],[@B9]\]. In this study, higher serum resistance was found in Δ*fur*, but this higher serum resistance was attenuated by further deletion of *ryhB* (Figure [4](#F4){ref-type="fig"}). We suggest the protective role of RyhB against serum killing is due to the activation of CPS biosynthesis.

In *E. coli*, RyhB plays a positive role in control of the intracellular iron concentration via the degradation of nonessential iron-using proteins or an increase in siderophore production \[[@B49]-[@B51]\]. In this study, we also found the deletion of *ryhB* in Δ*fur* decreased siderophore production on the CAS plate under iron-limiting condition (Figure [5](#F5){ref-type="fig"}). Consistent with *E. coli*\[[@B51]\], RyhB in *K. pneumoniae* regulates siderophore production by activating the expression of enterobactin system genes (*entCfepA*, and *fepB*). In addition, we found that RyhB may activate *iucA* and *fecA* expression. Since sRNA may positively regulate its target mRNAs via an anti-antisense mechanism to disrupt an intrinsic inhibitory structure in the 5′ mRNA region that sequesters the ribosome-binding site and the first translation codon \[[@B52],[@B53]\], the 5′-untranslated regions of the *iuc* and *fec* operons were analysed for sequences complementary to RyhB by prediction with the bioinformatics application RNAhybrid \[[@B54]\] (<http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.html>). However, no apparent base pairing was found in the 5′-untranslated region of the *iuc* or *fec* operons, suggesting that the activation of *iucA* and *fecA* by RyhB is not a result of direct interaction. Furthermore, RyhB was found to repress the expression of *fhuA* and *sitA* in *K. pneumoniae*. In *E. coli*, RyhB represses the expression of *fhuA*, which also corresponds to our results \[[@B35]\]. A possible paring between RyhB with the adjacent sequence of translational start site of *fhuA* and *sitA* was also predicted by the RNAhybrid algorithm. Alignment of the protected residues predicts that RyhB forms a 7 + 4 + 4 bp RNA duplex with the *sitA* mRNA (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1), but no apparent base pairing was found between RyhB and *fhuA*. However, the direct interaction of RyhB with the *sitA* mRNA remains to be confirmed. In *E. coli*, RyhB has been shown to repress several genes that are involved in iron-binding, which may increase the intracellular iron concentration, thereby allowing a better usage of iron and more complete Fur repression of these genes \[[@B35],[@B55]\]. Nevertheless, this possibility in *K. pneumoniae* needs to be proven by careful experiments. In this study, the coordinated action of Fur and RyhB was found to regulate the expression of the iron acquisition systems for maintaining intracellular iron homeostasis in *K. pneumoniae*.

Conclusions
===========

In this study, we provide an initial characterisation of *K. pneumoniae* RyhB*.* Our results suggest that RyhB plays an important role in the Fur regulon, which modulates the CPS biosynthesis and iron acquisition systems in *K. pneumoniae*, both of which contribute to the infectivity and survival of the bacterium.

Methods
=======

Bacterial strains, plasmids, and media
--------------------------------------

Bacterial strains and plasmids used in this study are listed in Table [2](#T2){ref-type="table"}. Primers used in this study are list in Additional file [2](#S2){ref-type="supplementary-material"}: Table S1. Bacterial were routinely cultured at 37°C in Luria-Bertani (LB) medium or M9 minimal medium supplemented with appropriate antibiotics. The antibiotics used include ampicillin (100 μg/ml), kanamycin (25 μg/ml), streptomycin (500 μg/ml), and tetracycline (12.5 μg/ml).

###### 

Bacterial strains and plasmids used in this study

  **Strains or plasmids**   **Descriptions**                                                                                                                           **Reference or source**
  ------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ -------------------------
  *K. pneumoniae*                                                                                                                                                       
  CG43S3                    CG43 Sm^r^                                                                                                                                 \[[@B56]\]
  Δ*lacZ*                   CG43S3Δ*lacZ*                                                                                                                              \[[@B17]\]
  Δ*fur*                    CG43S3Δ*fur*                                                                                                                               \[[@B22]\]
  Δ*lacZ*Δ*fur*             CG43S3Δ*lacZ*Δ*fur*                                                                                                                        \[[@B22]\]
  Δ*ryhB*                   CG43S3Δ*ryhB*                                                                                                                              This study
  Δ*fur*Δ*ryhB*             CG43S3Δ*fur*Δ*ryhB*                                                                                                                        This study
  Δ*lacZ*Δ*fur*Δ*ryhB*      CG43S3Δ*lacZ*Δ*fur*Δ*ryhB*                                                                                                                 This study
  Δ*galU*                   CG43S3Δ*galU*                                                                                                                              \[[@B57]\]
  *E. coli*                                                                                                                                                             
  DH5α                      *supE44* Δ*lacU169 (f80 lacZ*Δμ15) hsdR17 *recA1 endA1 gyrA96 thi-1 relA1*                                                                 \[[@B58]\]
  BL21-RIL                  *F*^*-*^*ompT hsdS*~*B*~*\[r*~*B*~^*-*^*m*~*B*~^*-*^*\]gal dcm* \[DE3\]                                                                    Laboratory stock
  S17-1 *λ pir* H1717       *hsdR recA pro* RP4-2 \[Tc::Mu; Km::Tn*7*\] \[*λpir*\] *araD139* Δ*lacU169 rpsL150 relA1 flbB5301 deoC1 ptsF25 rbsR aroB fhuF::λ placMu*   \[[@B59],[@B60]\]
  Plasmids                                                                                                                                                              
  pKAS46                    Positive selection suicide vector, *rpsL* Ap^r^ Km^r^                                                                                      \[[@B59]\]
  yT&A                      TA cloning vector                                                                                                                          Yeastern
  pRK415                    Broad-host-range IncP cloning vector, Tc^r^                                                                                                \[[@B61]\]
  pT7-7                     Cloning vector, Ap^r^                                                                                                                      \[[@B62]\]
  pETQ                      Km^r^, protein expression vector                                                                                                           \[[@B61]\]
  placZ15                   Cm^r^, promoter selection vector, *lacZ*^+^                                                                                                \[[@B17]\]
  pfur                      Tc^r^, 0.8-kb fragment containing a fur allele cloned into pRK415                                                                          \[[@B22]\]
  pET30c-Fur                Km^r^, 450-bp fragment encoding full-length Fur cloned into pET30c                                                                         \[[@B22]\]
  pRyhB04                   2.0 kb fragment containing an internal \~70-bp deletion in *ryhB* cloned into pKAS46                                                       This study
  pRyhB15                   Cm^r^, 178-bp fragment containing the region upstream of *ryhB* cloned into placZ15                                                        This study
  pOrf12                    Cm^r^, 500-bp fragment containing the region upstream of *Klebsiella K2 cps orf1-orf2* cloned into placZ15                                 \[[@B17]\]
  pOrf315                   Cm^r^, 900-bp fragment containing the region upstream of *Klebsiella K2 cps orf3-orf15* cloned into placZ15                                \[[@B17]\]
  pOrf1617                  Cm^r^, 300-bp fragment containing the region upstream of *Klebsiella K2 cps orf16-orf17* cloned into placZ15                               \[[@B17]\]
  pT7-7-p*ryhB*             178-bp fragment containing the putative *ryhB* promoter, cloned into pT7-7                                                                 This study
  pETQ-*ryhB*               Km^r^, 326-bp fragment containing the promoter and coding region of *ryhB* cloned into pETQ                                                This study

Construction of the gene-deletion mutants
-----------------------------------------

Specific gene deletion was introduced into *K. pneumoniae* CG43S3 using an allelic exchange strategy as previously described \[[@B57]\]. The pKAS46 system was used in the selection of the mutants \[[@B59]\], and the mutations were respectively confirmed by PCR and Southern hybridization (data not shown).

Measurement of promoter activity
--------------------------------

The promoter region of *ryhB* was PCR-amplified with primer pair pGT44/pGT45, and the amplicons were then cloned into placZ15 \[[@B63]\]. The promoter-reporter plasmids, pRyhB15, pOrf12, pOrf315, and pOrf1617, were individually mobilized into *K. pneumoniae* strains by conjugation from *E. coli* S17-1 λ*pir*. The bacteria were grown to logarithmic phase in LB broth with or without 200 μM Dip (OD~600~ of 0.7), and the β-galactosidase activity was measured as previously described \[[@B63]\].

EMSA
----

Recombinant *K. pneumoniae* Fur protein was expressed in *E. coli* and purified as previously described \[[@B22]\]. DNA fragment of the putative promoter region of *ryhB* was respectively PCR amplified by using specific primer sets (Table [2](#T2){ref-type="table"}). The purified His~6~-Fur was incubated with 10-ng DNA in a 15 μl solution containing 50 mM Tris--HCl (pH 7.5), 100 mM NaCl, 100 mM dithiothreitol, 200 μM MnCl~2~, and 1 μg/μl BSA at room temperature for 20 min. The samples were then loaded onto a native gel of 5% nondenaturing polyacrylamide containing 5% glycerol in 0.5× TB buffer (45 mM Tris--HCl, pH 8.0, 45 mM boric acid). Gels were electrophoresed with a 20-mA current at 4°C and then stained with SABR safe Gel stain (Invitrogen).

FURTA
-----

FURTA was performed according to the method described by Stojiljkovic *et al.*\[[@B64]\]. DNA sequences containing a putative Fur box were PCR amplified with specific primer sets and then cloned into pT7-7. The resulting plasmids were introduced into the *E. coli* strain H1717, and the transformants were plated onto MacConkey-lactose plates containing 100 μg/ml ampicillin and 30 μM Fe(NH~4~)~2~(SO~4~)~2~. The indicator strain H1717 contained a chromosomal *fhuF::lacZ* fusion, and a low affinity Fur box has been demonstrated in the *fhuF* promoter. The introduction of pT7-7 derived plasmids carrying Fur-binding sequences could thus cause the removal of Fur from the *fhuF* Fur box \[[@B60]\]. H1717 harboring pT7-7 was used as a negative control. Colony phenotype was observed after incubation at 37°C for 10 h. Red colony (Lac+) denoted a FURTA-positive phenotype and indicated the binding of Fur to the DNA sequence cloned into the pT7-7 plasmid.

Extraction and quantification of CPS
------------------------------------

CPS was extracted and quantified as previously described \[[@B65]\]. The glucuronic acid content, represents the amount of *K. pneumoniae* K2 CPS, was determined from a standard curve of glucuronic acid (Sigma-Aldrich) and expressed as micrograms per 10^9^ CFU \[[@B46]\].

qRT-PCR
-------

Total RNAs were isolated from early-exponential-phase grown bacteria cells by use of the RNeasy midi-column (QIAGEN) according to the manufacturer's instructions. RNA was DNase-treated with RNase-free DNase I (MoBioPlus) to eliminate DNA contamination. RNA of 100 ng was reverse-transcribed with the Transcriptor First Strand cDNA Synthesis Kit (Roche) using random primers. qRT-PCR was performed in a Roche LightCycler® 1.5 Instrument using LightCycler TaqMan Master (Roche). Primers and probes were designed for selected target sequences using Universal ProbeLibrary Assay Design Center (Roche-applied science) and listed in Additional file [2](#S2){ref-type="supplementary-material"}: Table S1. Data were analyzed using the real time PCR software of Roche LightCycler® 1.5 Instrument. Relative gene expressions were quantified using the comparative threshold cycle 2^-ΔΔCT^ method with 23S rRNA as the endogenous reference.

Bacterial survival in serum
---------------------------

Normal human serum, pooled from healthy volunteers, was divided into equal volumes and stored at −70°C before use. Bacterial survival in serum was determined with minor modifications \[[@B57]\]. First, The bacteria were grown to log phase in LB broth and the viable bacterial concentration was adjusted to 1 × 10^6^ colony forming units/ml. 1 ml of the cultures was washed twice by using phosphate-buffered saline (PBS) and resuspended in 1 ml PBS. The mixture containing 250 μl of the cell suspension and 750 μl of pooled human serum was incubated at 37°C for 60 min. The number of viable bacteria was then determined by plate counting. The survival rate was expressed as the number of viable bacteria treated with human serum compared to the number of pre-treatment. The assay was performed triple, each with triplicate samples. The data from one of the representative experiments are shown and expressed as the mean and standard deviation from the three samples. The 0% survival of *K. pneumoniae* CG43S3Δ*galU* served as a negative control.

CAS assay
---------

The CAS assay was performed according to the method described by Schwyn and Neilands \[[@B66]\]. Each of the bacterial strain was grown overnight in M9 minimal medium, and then 5 μl of culture was added onto a CAS agar plate. After 24 hr incubation at 37°C, effects of the bacterial siderophore production could be observed. Siderophore production was apparent as an orange halo around the colonies; absence of a halo indicated the inability to produce siderophores.

Statistical method
------------------

An unpaired *t*-test was used to determine the statistical significance and values of *P* \< 0.001 were considered significant. The results of CPS quantification and qRT-PCR analysis were derived from a single experiment representative of three independent experiments. Each sample was assayed in triplicate and the mean activity and standard deviation are presented.
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